MedTrace Logo

Survivorship of Attune Primary Total Knee Prosthesis

NCT01754363 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1542

Last updated 2026-05-08

No results posted yet for this study

Summary

This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.

Conditions

  • Noninflammatory Degenerative Joint Disease

Interventions

DEVICE

Attune Primary Total Knee Replacement

Patients will undergo a primary total knee replacement using one of the four configurations of the Attune knee (CR FB, CR RP, PS FB, PS RP).

Sponsors & Collaborators

  • DePuy International

    lead INDUSTRY

Principal Investigators

  • Allyson Morris · DePuy Synthes

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2030-02-01
Completion
2030-02-01
FDA Device
Yes

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Canada
  • Germany
  • Hong Kong
  • Malaysia
  • New Zealand
  • Singapore
  • South Korea
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01754363 on ClinicalTrials.gov